Total Payments
$8,035
2024 Payments
$908.88
Companies
39
Transactions
401
Medicare Patients
2,363
Medicare Billing
$482,552
Payment Breakdown by Category
Food & Beverage$7,689 (95.7%)
Travel$302.40 (3.8%)
Education$43.05 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,689 | 398 | 95.7% |
| Travel and Lodging | $302.40 | 1 | 3.8% |
| Education | $43.05 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,948 | 97 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,596 | 112 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $594.19 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $559.37 | 25 | $0 (2024) |
| GENZYME CORPORATION | $415.76 | 20 | $0 (2024) |
| Philips Electronics North America Corporation | $310.75 | 18 | $0 (2023) |
| Stryker Corporation | $302.40 | 1 | $0 (2018) |
| Insmed, Inc. | $302.28 | 12 | $0 (2024) |
| Mylan Specialty L.P. | $221.50 | 12 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $172.54 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $908.88 | 44 | GlaxoSmithKline, LLC. ($248.98) |
| 2023 | $1,405 | 63 | AstraZeneca Pharmaceuticals LP ($343.80) |
| 2022 | $1,249 | 60 | AstraZeneca Pharmaceuticals LP ($246.56) |
| 2021 | $608.95 | 37 | AstraZeneca Pharmaceuticals LP ($188.88) |
| 2020 | $726.63 | 40 | AstraZeneca Pharmaceuticals LP ($252.94) |
| 2019 | $1,489 | 75 | AstraZeneca Pharmaceuticals LP ($366.54) |
| 2018 | $1,185 | 52 | Stryker Corporation ($302.40) |
| 2017 | $461.53 | 30 | GlaxoSmithKline, LLC. ($184.86) |
All Payment Transactions
401 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| Category: Medical Device | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Respiratory | ||||||
| 06/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $30.42 | General |
| Category: Narcoplepsy | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Pulmonology | ||||||
| 05/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 368 | 629 | $149,975 | $79,812 |
| 2022 | 9 | 478 | 812 | $197,892 | $106,939 |
| 2021 | 9 | 686 | 1,162 | $265,035 | $142,194 |
| 2020 | 13 | 831 | 1,299 | $291,809 | $153,608 |
Total Patients
2,363
Total Services
3,902
Medicare Billing
$482,552
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 98 | 254 | $86,360 | $43,317 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 92 | $14,720 | $9,652 | 65.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 97 | $15,520 | $9,466 | 61.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 38 | $12,350 | $5,156 | 41.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 60 | $6,600 | $3,826 | 58.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 42 | $4,475 | $2,843 | 63.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 20 | $4,500 | $2,740 | 60.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 15 | $2,700 | $1,412 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,750 | $1,401 | 50.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 126 | 315 | $109,610 | $57,204 | 52.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 112 | 204 | $32,507 | $17,327 | 53.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 69 | $15,525 | $10,052 | 64.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 41 | $13,325 | $6,701 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 67 | $10,910 | $6,550 | 60.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 17 | $5,305 | $3,193 | 60.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 42 | $4,700 | $3,017 | 64.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 44 | $4,840 | $2,606 | 53.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 12 | 13 | $1,170 | $289.29 | 24.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 160 | 381 | $131,930 | $69,719 | 52.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 177 | 372 | $59,520 | $31,906 | 53.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 104 | $16,730 | $10,595 | 63.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 51 | 63 | $14,175 | $8,494 | 59.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 49 | 49 | $15,925 | $7,731 | 48.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 51 | 52 | $11,700 | $5,778 | 49.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 61 | 78 | $8,580 | $4,372 | 51.0% |
About Dr. Wei Bin, M.D
Dr. Wei Bin, M.D is a Pulmonary Disease healthcare provider based in Chester, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1619135043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wei Bin, M.D has received a total of $8,035 in payments from pharmaceutical and medical device companies, with $908.88 received in 2024. These payments were reported across 401 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,689).
As a Medicare-enrolled provider, Bin has provided services to 2,363 Medicare beneficiaries, totaling 3,902 services with total Medicare billing of $482,552. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Internal Medicine
- Location Chester, PA
- Active Since 06/02/2008
- Last Updated 11/14/2011
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1619135043
Products in Payments
- NUCALA (Biological) $594.59
- TRELEGY ELLIPTA (Drug) $584.47
- DUPIXENT (Biological) $507.88
- OFEV (Drug) $418.15
- BEVESPI AEROSPHERE (Drug) $392.51
- FASENRA (Drug) $391.70
- FASENRA (Biological) $386.79
- BREZTRI (Drug) $354.31
- WAKIX (Drug) $313.50
- NSE - CUTTING ACCESSORIES (Device) $302.40
- Arikayce (Drug) $302.28
- Wakix (Drug) $280.69
- ANORO (Drug) $204.69
- Yupelri (Drug) $201.41
- BREO (Drug) $134.64
- TEZSPIRE (Biological) $134.01
- ZENPEP (Drug) $117.28
- Prolastin-C Liquid (Biological) $115.53
- AIRSUPRA (Drug) $111.93
- ELIQUIS (Drug) $111.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chester
Asad Khan, Md, MD
Pulmonary Disease — Payments: $5,712
Pulmonary Disease $5,712
Gary Wendell, Md, MD
Pulmonary Disease — Payments: $5,580
Pulmonary Disease $5,580
Pierre Frederique, Md, MD
Pulmonary Disease — Payments: $3,791
Pulmonary Disease $3,791
Mohammad Farooq, Md, MD
Pulmonary Disease — Payments: $370.49
Pulmonary Disease $370.49
Leonard Berkowitz, Md, MD
Pulmonary Disease — Payments: $190.11
Pulmonary Disease $190.11
Kuo Tchong, Md, MD
Pulmonary Disease
Pulmonary Disease